The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy

Europace

Volumn 14, Issue 5, 2012, Pages 724-733

  O'Mahony, Constantinos ^a   Lambiase, Pier D ^a   Rahman, Shafiqur M ^a   Cardona, Montserrat ^a   Calcagnino, Margherita ^a   Quarta, Giovanni ^a   Tsovolas, Konstantinos ^a   Al Shaikh, Shereen ^a   McKenna, William ^a   Elliott, Perry ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Circadian rhythm; Electrocardiography; Hypertrophic cardiomyopathy; Implantable cardioverter defibrillator; Sudden cardiac death; Ventricular arrhythmia

Indexed keywords

ADULT; AGE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART ARRHYTHMIA; HEART PACING; HEART RHYTHM; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CIRCADIAN RHYTHM; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; RISK FACTORS; TACHYCARDIA, VENTRICULAR; VENTRICULAR PREMATURE COMPLEXES;

EID: 84860460987     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur362     Document Type: Article

References (37)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003;24:1965-91.
2. Elliott P, Spirito P. Prevention of hypertrophic cardiomyopathy-related deaths: Theory and practice. Heart 2008;94:1269-75.
3. Savage DD, Seides SF, Maron BJ, Myers DJ, Epstein SE. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1979;59:866-75. (Pubitemid 9163941)
4. Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;7:701-4. (Pubitemid 16164401)
5. Nicod P, Polikar R, Peterson KL. Hypertrophic cardiomyopathy and sudden death. N Engl J Med 1988;318:1255-7.
6. Taylor E, Berger R, Hummel JD, Dinerman JL, Kenknight B, Arria AM et al. Analysis of the pattern of initiation of sustained ventricular arrhythmias in patients with implantable defibrillators. J Cardiovasc Electrophysiol 2000;11:719-26. (Pubitemid 30457477)
7. Wood MA, Ellenbogen KA. Initiation of spontaneous ventricular tachycardia: From spark to fire. J Cardiovasc Electrophysiol 2000;11:727-9. (Pubitemid 30457478)
8. Saeed M, Link MS, Mahapatra S, Mouded M, Tzeng D, Jung V et al. Analysis of intracardiac electrograms showing monomorphic ventricular tachycardia in patients with implantable cardioverter-defibrillators. Am J Cardiol 2000;85:580-7.
9. O'Mahony C, Lambiase PD, Quarta G, Cardona M, Calcagnino M, Tsovolas K et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart 2012;98: 116-25.
10. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P et al. Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008;29:270-6.
11. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families. Heart 1997;77:130-2. (Pubitemid 27115795)
12. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000;36:2212-8.
13. Gimeno JR, Tome-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur Heart J 2009;30:2599-605.
14. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP et al. Efficacy of Implantable Cardioverter-Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy. N Engl J Med 2000;342:365-73. (Pubitemid 30084534)
15. Cha YM, Gersh BJ, Maron BJ, Boriani G, Spirito P, Hodge DO et al. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 2007;18:483-7. (Pubitemid 46650337)
16. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994;90:241-7. (Pubitemid 24203686)
17. Maron BJ, Semsarian C, Shen WK, Link MS, Epstein AE, Estes NA III et al. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy. Heart Rhythm 2009;6:599-602.
18. Adabag AS, Maron BJ. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol 2007;12:171-80. (Pubitemid 46900738)
19. Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ et al. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 2009;95:709-14.
20. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS et al. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JAMA 2007;298:405-12. (Pubitemid 47124061)
21. Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterlinski M, Maciag A et al. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: Efficacy and complications of the therapy in long-term follow-up. J Cardiovasc Electrophysiol 2010;21:883-9.
22. Woo A, Monakier D, Harris L, Hill A, Shah P, Wigle ED et al. Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy. Heart 2007;93:1044-5. (Pubitemid 47310979)
23. Sweeney MO. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2004;27:1292-1305. (Pubitemid 39281927)
24. Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 2001;104: 3069-75. (Pubitemid 34014059)
25. Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JT, de Belder MA et al. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation 1992;86:467-74.
26. Tsoutsman T, Lam L, Semsarian C. Genes, calcium and modifying factors in hypertrophic cardiomyopathy. Clin Exp Pharmacol Physiol 2006;33:139-45.
27. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation 1982;65:1388-94. (Pubitemid 12123632)
28. Maron BJ, Kogan J, Proschan MA, Hecht GM, Roberts WC. Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1994;23:1405-9. (Pubitemid 24158010)
29. Kiernan TJ, Weivoda PL, Somers VK, Ommen SR, Gersh BJ. Circadian rhythm of appropriate implantable cardioverter defibrillator discharges in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2008;31:1253-8.
30. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70:65-8.
31. Tofler GH, Gebara OC, Mittleman MA, Taylor P, Siegel W, Venditti FJ Jr et al. Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. The CPI Investigators. Circulation 1995;92: 1203-8.
32. Arntz HR, Willich SN, Schreiber C, Bruggemann T, Stern R, Schultheiss HP. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J 2000;21:315-20.
33. Muller D, Lampe F, Wegscheider K, Schultheiss HP, Behrens S. Annual distribution of ventricular tachycardias and ventricular fibrillation. Am Heart J 2003;146: 1061-5. (Pubitemid 37500781)
34. Young ME. Anticipating anticipation: Pursuing identification of cardiomyocyte circadian clock function. J Appl Physiol 2009;107:1339-47.
35. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results. Circulation 2004;110: 2591-6. (Pubitemid 39453007)
36. Lewandowski M, Sterlinski M, Maciag A, Syska P, Kowalik I, Szwed H et al. Longterm follow-up of children and young adults treated with implantable cardioverter-defibrillator: The authors' own experience with optimal implantable cardioverter-defibrillator programming. Europace 2010;12:1245-50.
37. Gronefeld GC, Israel CW, Padmanabhan V, Koehler J, Cuijpers A, Hohnloser SH. Ventricular rate stabilization for the prevention of pause dependent ventricular tachyarrhythmias: Results from a prospective study in 309 ICD recipients. Pacing Clin Electrophysiol 2002;25:1708-14. (Pubitemid 36026881)